Characteristics and associated cognitive indicators of decision-making decline over time in older people with mild

Mang Zhang1, Tao Li1, Huizi Li1

  • 1Dementia Care and Research Center, Peking University Institute of Mental Health (Sixth Hospital), No. 51 Huayuanbei Road, Beijing 100191, China; National Clinical Research Center for Mental Disorders, Key Laboratory for Mental Health, National Health Commission, Beijing, China; Beijing Municipal Key Laboratory for Translational Research on Diagnosis and Treatment of Dementia, China.

PubMed
Abstract

Insights

Decision-making (DM) declines in mild cognitive impairment (MCI) due to executive-social network collapse, not memory loss. Interventions targeting attention and socioemotional skills may preserve function.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) is associated with impaired decision-making (DM) under uncertainty.
  • This impairment can lead to increased financial vulnerability and suboptimal medical choices.
  • Understanding the progression of DM deficits in MCI is crucial for developing interventions.

Purpose of the Study:

  • To characterize changes in decision-making (DM) over two years in individuals with mild cognitive impairment (MCI).
  • To identify modifiable cognitive factors that contribute to functional preservation in MCI.
  • To differentiate DM decline drivers from memory decline in MCI.

Main Methods:

  • A two-year longitudinal study involving 52 MCI and 49 cognitively normal (CN) participants.
  • Annual assessment using the Iowa Gambling Task (IGT) modeled with Outcome-Representation Learning (ORL).
  • Quantification of learning rates, memory decay, and cognitive flexibility using ORL parameters; concurrent neuropsychological assessments.

Main Results:

  • MCI patients demonstrated a progressive inability to learn from penalties and adapt choice strategies.
  • Significant decline in cognitive flexibility was observed in the MCI group.
  • Network analysis revealed declining social cognition and executive function as primary drivers of DM deterioration.
  • Attention and social cognition deficits were linked to specific decision-making impairments.

Conclusions:

  • Mild cognitive impairment (MCI) involves significant decision-making (DM) disintegration, driven by executive-social network collapse.
  • Memory decline is not the primary driver of DM deficits in MCI.
  • Targeted interventions focusing on attentional control and socioemotional processing show promise for mitigating functional risks in MCI.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
267
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
165
Decision Making01:20

Decision Making

Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
230
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
123
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666